- August 20, 2024
George Mason scientist Fereshte Ghahari Kermani received the prestigious Early Career Development (CAREER) Program grant from the National Science Foundation to continue her research on the complex quantum phases in graphene materials.
- George Mason agricultural tool is another step closer to helping U.S. farmers, thanks to NSF supportAugust 13, 2024
The user-inspired CropSmart Digital Twin provides on-demand, decision-ready solutions to take the guesswork out of crop management decisions.
- August 14, 2024
Professor John Cantiello reviews the literature to find out who is cheating, how, and how to head it off
- August 9, 2024
As George Mason doctoral student Jericho McLeod reviewed literature on disease transmission as part of his PhD work, he and George Mason professor Eduardo López noticed a gap in the models and now seek to correct it.
- August 8, 2024
With the support of a 4-VA award, George Mason researcher Sabine Doebel had the opportunity to collaborate with colleague Angeline Lillard, a widely respected developmental psychologist at the University of Virginia.
- August 6, 2024
The economic data on climate and business outcomes paints a picture of profound disruption beneath a placid-seeming surface.
- August 5, 2024
Mechanical engineer Jeffrey Moran, whose lab focuses on self-propelled micro- and nanoparticles, has loved outer space since childhood. Now, one of his experiments, exploring aerosol thermophoresis, will be carried out on the International Space Station.Â
- July 30, 2024
Through 4-VA@Mason, ÑÇÖÞAV faculty members have embarked on new pilot research projects in collaboration with higher education institutions throughout Virginia.
- July 30, 2024
Did Homo naledi bury their dead? A Netflix documentary says yes, but new research published by George Mason anthropology professor Kimberly Foecke says no.
- July 25, 2024
Researchers in George Mason’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study, published in Nature’s Gene Therapy, that found a human immunodeficiency virus (HIV)-like virus particle that could cease the need for lifelong medications.